vancing the development of new technologies to address national missions.7 Because they are flexible and can be organized on an ad hoc basis, partnerships are an effective means to rapidly focus diverse expertise and innovative technologies to help counter new threats.


The National Institute of Allergies and Infectious Diseases at the National Institutes of Health, for example, has rapidly expanded its efforts in support of research on possible agents of bio-terrorism in response to recent threats and attacks. Specifically, NIAID has expanded research to develop countermeasures—including vaccines, therapeutics, and diagnostic tests—needed to respond and control the release of agents of bio-terrorism. An important tool in this effort has been the SBIR program. See NIAID FY 2003 Budget Justification Narrative at <>.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement